98%
921
2 minutes
20
Background: Abernethy malformation (AM) is a rare vascular anomaly characterized by the diversion of splanchnic venous blood directly into the systemic circulation, bypassing the liver. We present the clinical features, diagnostic workup, and follow-up of a 6-day-old Chinese male with type II AM combined with Noonan syndrome (NS).
Case Presentation: The patient was prenatally suspected of having AM based on ultrasonographic findings, which were postnatally confirmed through enhanced computed tomography (CT) and magnetic resonance (MR) imaging. Due to dysmorphic facial features, whole-exome sequencing (WES) was performed, identifying a heterozygous c.848G > A (p. Arg283Gln) variant in the LZTR1 gene (NM_006767.4), consistent with NS. During follow-up, the patient exhibited progressive elevation of liver enzymes and hyperammonemia, prompting laparoscopic portosystemic shunt ligation at six months of age. Postoperatively, the patient demonstrated rapid biochemical normalization and sustained clinical improvement.
Conclusions: In patients with RASopathies, clinicians should maintain a high index of suspicion for AM and NS. Comprehensive vascular evaluation, particularly imaging screening of the portal venous system, is essential to avoid missed diagnoses and ensure timely intervention, thereby improving patient outcomes. A multidisciplinary approach that integrates genetic testing, advanced imaging, and surgical expertise is essential for optimizing outcomes in these complex cases.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12254992 | PMC |
http://dx.doi.org/10.1186/s12887-025-05726-1 | DOI Listing |
J Vasc Interv Radiol
September 2025
Chief consultant, Heart failure clinic & Echocardiography, GKNM hospital, Coimbatore, India.
Int J Neonatal Screen
August 2025
Department of Pediatrics, Saitama Medical University, Saitama 350-0495, Japan.
Congenital portosystemic shunts (CPSSs) are often associated with life-threatening systemic complications, which may be detected by identifying hypergalactosemia in newborn screening (NBS). However, diagnosing CPSS at an early stage is not easy. The purpose of this study was to predict CPSS early using screening values and general blood tests.
View Article and Find Full Text PDFLiver Cancer
August 2025
Institute of Liver Studies, King's College London, London, UK.
Introduction: Patients born with congenital porto-systemic shunts have been shown to have a high risk of benign and malignant liver tumors in otherwise healthy livers. This study aimed to evaluate the genetic landscape of liver tumors in patients with congenital porto-systemic shunts (CPSS) and correlate genotype with histological findings.
Methods: Nodules from patients with CPSS and sporadic pediatric focal nodular hyperplasia (FNH) or FNH-like nodules were evaluated histologically and sequenced for a panel of 50 genes using next-generation sequencing.
Dig Liver Dis
August 2025
Department of radiology, The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, 041030 Baotou, China. Electronic address:
Cardiol Young
July 2025
Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Objective: To highlight veno-venous collaterals and portosystemic shunts as possible causes of cyanosis requiring evaluation or treatment below the diaphragm in patients with single-ventricle physiology during staged palliation.
Background: Cyanosis can complicate staged single-ventricle palliation and is often evaluated with imaging isolated to the thorax. As a result, lesions below the diaphragm, such as veno-venous collaterals and portosystemic shunts, may be missed.